Draft-Specimen Test Schedule 10.18.21 HC.xlsx
XLSX spreadsheet 6 MB Posted
- Attached to
- Reference Laboratory Testing Services
- Solicitation number
- 22-000946
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Draft Statement of Work - DLM Reference Lab Testing 10.08.21 HC-FINAL.doc | DOC document | |
| HHS Subcontracting Plan Template.docx | DOCX document | |
| Draft-Evaluation Factors.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
63311
| SPECIMEN TEST SCHEDULE ATTACHMENT 4 (Estimated Test List subject to change due to programmatic requirements; see SOW) | |||||||||||||||
| *FILL IN PRICING FOR EACH TEST LISTED/TOTALS ARE CALCULATED AT THE BOTTOM AFTER THE LAST TEST* | Location | ||||||||||||||
| Estimated Volume | Bldg 10, RM 2C324 | ||||||||||||||
| Test Name | (12 months) | Turnaround Time | Methodology | daily, after 3pm | Base Yr Price Per Test | Opt 1 Price Per Test | Opt 2 Price Per Test | Opt 3 Price Per Test | Opt 4 Price Per Test | Base Yr Price Per Test x Estimated Volume | Opt 1 Price Per Test x Estimated Volume | OPT 2 Price Per Test x Estimated Volume | OPT 3 Price Per Test x Estimated Volume | Opt 4 Price Per Test x Estimated Volume | |
| Antinuclear Antibodies (ANA), Serum | 2376 | 1 day | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| DNA Double-Stranded Antibodies, IgG, Serum | 1932 | 1 to 3 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Phospholipid (Cardiolipin) Antibodies, IgG and IgM, Serum | 1272 | Same day/1 to 2 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| QuantiFERON-TB Gold Plus, Blood | 1296 | 2 to 4 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Antibody to Extractable Nuclear Antigen Evaluation, Serum | 1144 | Same day/1 to 2 days | Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Hemoglobin Variant, A2 and F Quantitation, Blood | 1110 | Same day/1 to 2 days | Capillary Electrophoresis (CE) | ||||||||||||
| Zinc, Serum | 1004 | 1 to 3 days | Dynamic Reaction Cell-Inductively Coupled Plasma-Mass Spectrometry (DRC-ICP-MS) | ||||||||||||
| Methylmalonic Acid, Quantitative, Serum | 968 | 3 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Cortisol, Saliva | 856 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Cyclic Citrullinated Peptide Antibodies, IgG, Serum | 778 | Same day/1 to 3 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Thiamine (Vitamin B1), Whole Blood | 656 | 2 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Herpes Simplex Virus (HSV) Type 1- and Type 2-Specific Antibodies, IgG, Serum | 628 | Same day/1 to 2 days | Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Myeloperoxidase Antibodies, IgG, Serum | 628 | 1 to 4 days | Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Proteinase 3 Antibodies, IgG, Serum | 614 | Same day/1 to 3 days | Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Chromosome Analysis, Hematologic Disorders, Bone Marrow | 604 | 9 to 11 days | Cell Culture without Mitogens followed by Chromosome Analysis | ||||||||||||
| Beta-2 Glycoprotein 1 Antibodies, IgG and IgM, Serum | 590 | Same day/1 to 6 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Posaconazole, Serum | 562 | 2 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Cytokine Panel 13 | 560 | 1 to 8 days | Quantitative Multiplex Bead Assay | ||||||||||||
| Chromogranin A, Serum | 538 | Same day/1 to 3 days | Immunofluorescent Assay (IFA) | ||||||||||||
| Renin Activity, Plasma | 516 | 2 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Cyclic Adenosine Monophosphate (cAMP), Urinary Excretion, Serum and Urine | 508 | 2 to 9 days | Enzymatic Colorimetric Assay; High-Performance Liquid Chromatography (HPLC) | ||||||||||||
| Complement, Total, Serum | 460 | 1 to 2 days | Automated Liposome Lysis Assay | ||||||||||||
| Erythropoietin, Serum | 444 | 1 to 3 days | Immunoenzymatic Assay | ||||||||||||
| Aspergillus (Galactomannan) Antigen, Serum | 426 | 1 to 4 days | Enzyme Immunoassay (EIA) | ||||||||||||
| Metanephrines, Fractionated, Free, Plasma | 412 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Tryptase, Serum | 384 | 1 to 5 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Mitochondrial Antibodies (M2), Serum | 348 | 1 day | Enzyme Immunoassay (EIA) | ||||||||||||
| 1,3-Beta-D-Glucan (Fungitell), Serum | 348 | 1 to 2 days | Protease Zymogen-Based Colorimetic Assay | ||||||||||||
| Hemoglobin Electrophoresis Evaluation, Blood | 341 | 2 to 25 days | Varies: Consultative Interpretation, Capillary Electrophoresis (CE), Cation Excahnge/High-Performance Liquid Chromatography (HPLC); Isoelectric Focusing (IEF); Mass Spectrometery (MS); Flow Cytometry; Isopropanol and Heat Stability; Medical Interpretation | ||||||||||||
| Smooth Muscle Antibody Screen, Serum | 322 | 2 to 4 days | Indirect Immunofluorescence | ||||||||||||
| Lyme Disease Serology, Serum | 320 | 1 to 4 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Copper, Serum | 312 | 1 to 3 days | Dynamic Reaction Cell-Inductively Coupled Plasma-Mass Spectrometry (DRC-ICP-MS) | ||||||||||||
| Fatty Acid Profile, Essential, Serum | 304 | 4 to 7 days | Gas Chromatography-Mass Spectrometry (GC-MS) Stable Isotope Dilution Analysis | ||||||||||||
| Epstein-Barr Virus (EBV), IgG Antibody to Early Antigen, Serum | 284 | Same day/1 to 3 days | Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Estrone, Serum | 276 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Tissue Transglutaminase Antibody, IgA, Serum | 270 | Same day/1 to 4 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Caffeine, Serum | 240 | Same day/1day | Enzyme Multiplied Immunoassay Technique (EMIT) | ||||||||||||
| Beta-CrossLaps, Serum | 236 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Streptococcus pneumoniae IgG Antibodies, 23 Serotypes, Serum | 232 | 4 to 6 days | Microsphere Photometry | ||||||||||||
| Procollagen I Intact N-Terminal, Serum | 230 | 1 to 5 days | Radioimmunoassay (RIA) | ||||||||||||
| Breast Carcinoma-Associated Antigen, Serum | 228 | Same day/1 to 2 days | Chemiluminometric Immunoassay | ||||||||||||
| IgG Subclasses, Serum | 222 | Same day/1 to 3 days | Nephelometry | ||||||||||||
| Interleukin-10 (IL-10) Serum | 216 | 3 to 11 days | Multiplex Array Electrochemiluminescence | ||||||||||||
| Paroxysmal Nocturnal Hemoglobinuria, PI-Linked Antigen, Blood | 216 | 1 to 2 days | Immunophenotyping | ||||||||||||
| Citrate Excretion, 24 Hour, Urine | 214 | Same day/1 day | Enzymatic | ||||||||||||
| Interleukin 6, Plasma | 214 | 1 to 8 days | Electrochemiluminescence (ECL) | ||||||||||||
| Interleukin 2 Receptor, Soluble | 212 | 1 to 6 days | Quantitative Multiplex Bead Assay | ||||||||||||
| Tetanus Toxoid IgG Antibody, Serum | 208 | Same day/1 to 4 days | Enzyme Immunoassay (EIA) | ||||||||||||
| Synthetic Glucocorticoid Screen, Serum | 206 | 2 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Stable Isotope Dilution Analysis | ||||||||||||
| Varicella-Zoster Antibody, IgM and IgG, Serum | 206 | Same day/1 to 3 days | Immunofluorescence Assay (IFA); Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Gastrin, Serum | 192 | Same day/1 to 3 days | Automated Chemiluminescent Immunometric Assay | ||||||||||||
| Liver/Kidney Microsome Type 1 Antibodies, Serum | 174 | 1 to 4 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation, Serum | 172 | 5 to 10 days | Affinity Chromatography-Mass Spectrometry (MS) | ||||||||||||
| Diphtheria Toxoid IgG Antibody, Serum | 162 | Same day/1 to 4 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Alpha-2-Macroglobulin, Serum | 160 | Same day/1 to 2 days | Nephelometry | ||||||||||||
| Calprotectin, Feces | 160 | 3 to 5 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Cytokine Panel, Plasma | 160 | 1 to 5 days | Bead-Based Multiplex Immunoassay | ||||||||||||
| Toxoplasma gondii Antibody, IgM, Serum | 160 | Same day/1 to 3 days | Multiplex Flow Immunoassay (MFI) | ||||||||||||
| Hepatitis D Virus Total Antibodies, Serum | 158 | 1 to 7 days | Enzyme Immunoassay (EIA) | ||||||||||||
| Pancreatic Polypeptide, Plasma | 150 | 3 to 8 days | Radioimmunoassay (RIA) | ||||||||||||
| Sickle Solubility, Blood | 150 | 1 to 4 days | Hemoglobin S Solubility | ||||||||||||
| Calcitonin, Serum | 148 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Bone Alkaline Phosphatase, Serum | 146 | 1 to 3 days | Immunoenzymatic Assay | ||||||||||||
| Fructosamine, Serum | 146 | Same day/1 to 2 days | Colorimetric Rate Reaction | ||||||||||||
| Aspergillus Antigen, Bronchoalveolar Lavage | 144 | 1 to 2 days | Enzyme Immunoassay (EIA) | ||||||||||||
| Metanephrines, Fractionated, 24 Hour, Urine | 142 | 3 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Stable Isotope Dilution Analysis | ||||||||||||
| Ova and Parasite, Concentrate and Permanent Smear, Microscopy, Feces | 142 | 2 to 4 days | Microscopic | ||||||||||||
| Beta-Human Chorionic Gonadotropin, Quantitative, Serum | 138 | 1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Lysozyme (Muramidase), Plasma | 138 | 2 to 5 days | Turbidimetric | ||||||||||||
| Prostatic Acid Phosphatase, Serum | 136 | Same day/1 to 3 days | Automated Chemiluminescent Immunometric Assay | ||||||||||||
| Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Serum | 134 | 3 to 6 days | Radioimmunoassay (RIA) | ||||||||||||
| Chlamydia trachomatis and Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies | 132 | 1 to 4 days | Transcription Mediated Amplification | ||||||||||||
| 5-Hydroxyindoleacetic Acid, 24 Hour, Urine | 132 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Haemophilus influenzae Type B Antibody, IgG, Serum | 126 | 1 to 6 days | Enzyme Immunoassay (EIA) | ||||||||||||
| Phospholipase A2 Receptor Antibodies, Serum | 126 | 3 to 7 days | Enzyme-Linked Immunosorbent Assay (ELISA); Indirect Immunofluorescence Assay (IFA) | ||||||||||||
| Catecholamine Fractionation, Free, 24 Hour, Urine | 124 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Fungitell, CSF | 124 | 1 to 6 days | Limulus Amebocyte Lysate (LAL) Pathway | ||||||||||||
| Acetylcholine Receptor (Muscle AChR) Binding Antibody, Serum | 116 | 3 to 6 days | Radioimmunoassay (RIA) | ||||||||||||
| Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum | 114 | 2 days | Indirect Immunofluorescence | ||||||||||||
| NTX-Telopeptide, Urine | 110 | Same day/1 to 5 days | Chemiluminescence Immunoassay; Enzymatic Colorimetric Assay | ||||||||||||
| Sulfamethoxazole, Serum | 108 | 2 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Vascular Endothelial Growth Factor, Plasma | 108 | 1 to 8 days | Electrochemiluminescence | ||||||||||||
| OncoHeme Next-Generation Sequencing for Myeloid Neoplasms, Varies | 104 | 14 to 21 days | Somatic Mutation Detection by Next-Generation Sequencing (NGS) | ||||||||||||
| Carnitine, Serum | 102 | 2 to 5 days | Flow Injection Analysis-Tandem Mass Spectrometry (FIA-MS/MS) | ||||||||||||
| Serotonin, Blood | 100 | 4 to 6 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Thyroid-Stimulating Immunoglobulin, Serum | 100 | 2 to 6 days | Recombinant Bioassay | ||||||||||||
| Antimullerian Hormone, Serum | 98 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Oxalate, 24 Hour, Urine | 98 | 3 to 5 days | Enzymatic | ||||||||||||
| Lysozyme (Muramidase), Plasma | 94 | 2 to 5 days | Turbidimetric | ||||||||||||
| HIV-1 and HIV-2 Antibody Confirmation and Differentiation, Plasma | 92 | 1 to 3 days | Rapid Immunochromatographic Assay | ||||||||||||
| Immunoglobulin D (IgD), Serum | 92 | Same day/1 to 3 days | Nephelometry | ||||||||||||
| Lipoprotein (a), Serum | 90 | 1 to 3 days | Immunoturbidimetric Assay | ||||||||||||
| Alpha-Subunit Pituitary Tumor Marker, Serum | 88 | 1 to 7 days | Immunochemiluminescent Assay | ||||||||||||
| Paraneoplastic, Autoantibody Evaluation, Serum | 88 | 10 to 17 days | Varies based on test component: indirect immunofluorescence assay, radioimmunoassay, sorting assay/flow cytometry, western blot, immunoblot, cell-binding assay | ||||||||||||
| Cashew, IgE, Serum | 84 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| T3 (Triiodothyronine), Total, Serum | 84 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Thyrotropin Receptor Antibody, Serum | 84 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Vanillylmandelic Acid, 24 Hour, Urine | 82 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Walnut-Food, IgE, Serum | 79 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Peanut, IgE, Serum | 79 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Platelet Transmission Electron Microscopic Study, Whole Blood | 78 | 10 days | Transmission Electron Microscopy | ||||||||||||
| Milk, IgE, Serum | 74 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Amino Acids, Quantitative, Plasma | 72 | 3 to 5 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Codfish, IgE, Serum | 72 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Egg White, IgE, Serum | 72 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Zinc Transporter 8 (ZnT8) Antibody, Serum | 72 | 3 to 7 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Histamine, Whole Blood | 72 | 1 to 11 days | Quantitative Enzyme-Linked Immunosorbent Assay | ||||||||||||
| Uric Acid, Body Fluid | 72 | 1 to 5 days | Quantitative Spectrophotometry | ||||||||||||
| Mycophenolic Acid, Serum | 70 | Same day/1 to 3 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Crab, IgE, Serum | 70 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Intact Fibroblast Growth Factor 23, Serum | 70 | 1 to 7 days | Chemiluminescence Based Quantitative Sandwich Immunoassay | ||||||||||||
| Sesame Seed, IgE, Serum | 70 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Shrimp, IgE, Serum | 70 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Busulfan, Pharmacokinetics, Plasma | 66 | Same day/1 to 3 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| Islet Antigen 2 (IA-2) Antibody, Serum | 66 | 3 to 9 days | Radioimmunoassay (RIA) | ||||||||||||
| Insulin Antibodies, Serum | 66 | 3 to 9 days | Radioimmunoassay (RIA) | ||||||||||||
| Chlamydia trachomatis, Miscellaneous Sites, Nucleic Acid Amplification, Varies | 66 | 1 to 4 days | Transcription Mediated Amplification | ||||||||||||
| Neisseria gonorrhoeae, Miscellaneous Sites, Nucleic Acid Amplification, Varies | 66 | 1 to 4 days | Transcription Mediated Amplification | ||||||||||||
| Rapid Plasma Reagin Titer, Serum | 66 | Same day/1day | Flocculation/Agglutination | ||||||||||||
| Almond, IgE, Serum | 65 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Hepatitis E Virus IgM Antibody Screen with Reflex to Confirmation, Serum | 64 | 1 to 7 days | Enzyme Immunoassay (EIA) | ||||||||||||
| C-Peptide, Serum | 62 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Wheat, IgE, Serum | 62 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Dexamethasone | 62 | 3 to 20 days | High-Pressure Liquid Chromatography/Tandem Mass Spectrometry (HPLC/MS-MS) | ||||||||||||
| 21-Hydroxylase Antibodies, Serum | 60 | 2 to 9 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Nicotine and Metabolites, Serum | 60 | 2 to 4 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | ||||||||||||
| VDRL Titer, Spinal Fluid | 60 | 1 day | Flocculation/Agglutination | ||||||||||||
| Glucagon, Plasma | 58 | 2 to 6 days | Immunoassay | ||||||||||||
| Hepatitis E Virus IgG Antibody, Serum | 58 | 1 to 7 days | Enzyme Immunoassay (EIA) | ||||||||||||
| Lyme Disease Antibody, Immunoblot, Serum | 58 | Same day/1 to 3 days | Immunoblot Microarray | ||||||||||||
| Pyruvate, Spinal Fluid | 58 | 6 to 8 days | Spectrophotometry (SP) | ||||||||||||
| Growth Differentiation Factor 15, Plasma | 58 | 8 to 15 days | Enzyme-Linked Immunosorbent Assay (ELISA) | ||||||||||||
| Pistachio, IgE, Serum | 58 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Soybean, IgE, Serum | 58 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Adrenocorticotropic Hormone, Plasma | 56 | Same day/1 to 3 days | Electrochemiluminescence Immunoassay (ECLIA) | ||||||||||||
| Fat, Feces | 56 | 1 to 3 days | Nuclear Magnetic Resonance (NMR) Spectroscopy | ||||||||||||
| Helicobacter pylori with Clarithromycin Resistance Prediction, Molecular Detection, PCR, Feces | 56 | 3 to 4 days | Real-Time Polymerase Chain Reaction (PCR) | ||||||||||||
| Brazil Nut, IgE, Serum | 55 | Same day/1 to 3 days | Fluoresence Enzyme Immunoassay (FEIA) | ||||||||||||
| Herpesvirus 8 (HHV-8) DNA, Quantitative Real-Time PCR | 54 | 1 to 5 days | Herpes Virus 8 DNA, Quant RT-PCR | ||||||||||||
| Pancreastatin, Serum | 54 | 7 to 11 days | Enzyme Immune Assay (EIA) | ||||||||||||
| N-Methylhistamine, Random, Urine | 54 | 3 to 7 days | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS); Enzymatic Colorimetric Assay | ||||||||||||
| Pyruvic Acid, Blood | 54 | 6 to 8 days | Spectrophotometry (SP) | ||||||||||||
| TOTAL | ERROR:#REF! | ERROR:#REF! | ERROR:#REF! | ERROR:#REF! | ERROR:#REF! | ERROR:#REF! |
Attachment 4 -Specimen Test Schedule 11-23-15 Final.xlsx
File details come from the government source that posted it. Updated .